Drosophila mutant model of Parkinson&#8217;s Disease revealed an unexpected olfactory performance: morphofunctional evidences by De Rose, Francescaelena et al.
Research Article
Drosophila Mutant Model of Parkinson’s
Disease Revealed an Unexpected Olfactory Performance:
Morphofunctional Evidences
Francescaelena De Rose,1 Valentina Corda,2 Paolo Solari,1
Patrizia Sacchetti,3 Antonio Belcari,3 Simone Poddighe,1 Sanjay Kasture,4 Paolo Solla,5
Francesco Marrosu,5 and Anna Liscia1
1Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
2Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy
3Department of Agricultural Biotechnology, Section of Plant Protection, University of Florence, Firenze, Italy
4Pinnacle Biomedical Research Institute, Bhopal, India
5Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy
Correspondence should be addressed to Anna Liscia; liscia@unica.it
Received 25 May 2016; Revised 2 August 2016; Accepted 4 August 2016
Academic Editor: Jan Aasly
Copyright © 2016 Francescaelena De Rose et al.This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in anymedium, provided the originalwork is properly cited.
Parkinson’s disease (PD) is one of themost commonneurodegenerative diseases characterized by the clinical triad: tremor, akinesia,
and rigidity. Several studies have suggested that PD patients show disturbances in olfaction as one of the earliest, nonspecific
nonmotor symptoms of disease onset. We sought to use the fruit fly Drosophila melanogaster as a model organism to explore
olfactory function in LRRK loss-of-functionmutants, which was previously demonstrated to be a useful model for PD. Surprisingly,
our results showed that the LRRK mutant, compared to the wild flies, presents a dramatic increase in the amplitude of the
electroantennogram responses and this is coupled with a higher number of olfactory sensilla. In spite of the above reported results,
the behavioural response to olfactory stimuli inmutant flies is impaired compared to that obtained inwild type flies.Thus, behaviour
modifications andmorphofunctional changes in the olfaction of LRRK loss-of-functionmutantsmight be used as an index to explore
the progression of parkinsonism in this specific model, also with the aim of studying and developing new treatments.
1. Introduction
The olfactory system represents the most common and
ancient sensory system within the animal kingdom, from
single-celled organisms through higher animals [1], and one
of the most important sensory modalities, due to its crucial
role in conveying information about the external world to
the nervous system. In this respect, dysfunctions of the
olfactory system may have negative effects on the quality
of life [2] and in some cases it has been associated with a
higher mortality risk [3]. Several studies have demonstrated
the connection between smell dysfunctions and Parkinson’s
disease (PD) [4–9]. Although PD is usually considered as
a movement disorder, several studies have shown that PD
nonmotor symptoms may have greater impact on quality-of-
life measures, institutionalisation rates, or health economics
(for a review, see [10]). Moreover, among PD nonmotor
disorders, olfactory disturbances may often precede motor
symptoms, representing a potential predicting marker for
PD [11]. Indeed, the same presence of Lewy bodies in the
substantia nigra [12], strictly related to the onset of typical
PD motor symptoms, is a later step in the progression of the
pathology. Indeed, initial presence of Lewy bodies has been
clearly observed in themedulla oblongata and in the olfactory
bulb, thus preceding the successive involvement of midbrain,
diencephalic nuclei, and neocortex [13].
Although it is now clear that PD is associated with a
combination of risk factors, including environmental noxious
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agents and genetic predisposition [14], which of themany risk
factors may be associated with the timing of disease onset is
not known.
Furthermore, regarding genetic predisposition, only a
limited percentage is due to monogenic forms of the disease
[15]. Among the several genetic mutations implicated in
PD aetiology, those associated with the leucine-rich repeat
kinase 2 gene (LRRK2) are actually known as responsible
for the most common familial and sporadic disorder cases
[16–18]. Two more common variations in the LRRK2 gene
have been described: G2019S and G2385R [19]. Among them,
the most common (G2019S) accounts for 3–6% of familial
dominant PD and for 1-2% of sporadic forms with a north-
south gradient of G2019S frequency in European countries
and reaching frequency up to 41% in North African cases
[20], while the second variation (G2385R) is commonmainly
in Asian populations [19, 21]. To date, apparent discrepancies
between these variations have been reported, suggesting
a more complicated phenotype in the G2385R mutation
carriers than in LRRK2 G2019S mutation carriers [19].
Although the evidence about LRRK2 role in inflam-
matory processes and in the endolysosomal system and
cytoskeleton impairment has been identified [22], its involve-
ment in PD development is still not fully defined. Interest-
ingly, different studies highlighted that carriers of a given
LRRK2 mutation show a clinical and pathological variability
in the manifestation of the disorder, with nigral degeneration
associated with absence and limited or wide diffusion of
Lewy bodies [16, 17, 23–25].This phenotypic and pathological
variability, however, is found in nearly all monogenic causes
of PD, even within nuclear families (e.g., SNCA A53T) [26].
Some variability has also been observed regarding non-
motor symptoms, where LRRK2 G2019S olfactory phenotype
may be less pronounced than idiopathic PD and possibly
G2385Rmutation, and it is not clear that all G2019Smutation
carriers have olfactory impairment [19, 27–36].
Given the above reported phenotypic variability in PD
olfactory dysfunction, it seems of particular interest to have a
simple model to study this nonmotor symptom, particularly
in a LRRK2 mutant.
The LRRK2 gene coding for unusually large protein
composed of 2527 amino acids is widely expressed in the
brain and other organs [37–40]. The LRRK2 roles, listed in
the Berwick and Harvey review [22], include neurogenesis
and neurite outgrowth, cytoskeleton assembly, endocyto-
sis/vesicles trafficking, and autophagy coordination.
LRRK2 is a member of the ROCO protein family char-
acterized by the presence of two conserved domains: a
Roc (Ras in complex proteins) domain belonging to the
Ras/GTPase superfamily and a COR domain (C-terminal of
Roc). Three further conserved domains have been described:
a leucine-rich repeat (LRR); a tyrosine kinase catalytic
domain (MAPKKK); and finally a WD40 domain [17]. This
latter is known to be crucial in several basic cell functions
such as vesicle sorting during endocytosis and exocytosis of
synaptic vesicles as well as vesicle-mediated transport and
cytoskeleton assembly [41, 42].
Recently, De Rose et al. [43] reported that Drosophila
LRRK2 loss-of-function mutant for deletion of the domain
WD40 (LRRK2WD40; LRRKex1 mutant, [44, 45]) showed a
motor age-dependent impairment and a correlated mito-
chondrial impairment in the thoracic ganglia. Besides, a
mitochondrial impairment was detected in the antennal lobe
area, where olfactory signal from the peripheral chemore-
ceptors projects. Similarly, a morphological impairment was
reported by Poddighe et al. [46] in another Drosophila
mutant such as PINK1B9 which also showed a decrease in
the olfactory detection, both in the electrophysiologically
recorded olfactory signals and in the olfactory behaviour.
On this basis, the aim of this study was to estimate
any possible olfactory dysfunction in the Drosophila LRRK2
model of PD correlated to LRRK2 mutation (LRRKWD40).
This model most closely approximates human LRRK2
G2385Rmutations,which occur in the humanWD40domain
and are a risk factor for PD. The results showed that the
LRRKWD40mutant presents an unexpected dramatic increase
in the amplitude of electrophysiological responses, but a
decrease in the olfactory discrimination, with respect to wild
type flies (WT).
2. Materials and Methods
2.1. Insects. For these experiments adult wild type (WT;
Canton-S) and LRRKWD40 mutant (LRRKex1, #34750, from
Bloomington Stock Center) Drosophila melanogaster (Dm)
males were used. Soon after emergence from pupae, WT or
LRRKWD40 mutant males were separated from females. WT
and mutant flies were reared on a standard cornmeal-yeast-
agar medium in controlled environmental conditions (24-
25∘C; 60% relative humidity; light/dark = 12/12 hours). Flies
ranging 10–15 days in age were tested according to previous
experiments [43].
2.2. Electroantennograms (EAGs) Recordings. Electroanten-
nogram (EAG) recordings were performed in vivo as previ-
ously described [47, 48].
By taking into account the circadian cycle in olfactory
sensitivity [49], WT and mutant flies were always tested
in parallel. Briefly, living 10- to 15-day-old male flies were
singly inserted in a 100𝜇L truncated plastic pipette, with the
head protruding at the tip. The preparation was fixed with
dental wax on a microscope slide and positioned under the
viewer of an Olympus BX51WI light microscope (Olympus,
Tokyo, Japan). Glass capillaries with a silver wire were filled
with a conductive 0.15M NaCl solution. The recording glass
electrode was gently placed on the tip of the antennal
funiculus, whereas the reference electrode was inserted in
the compound eye. The EAG signal was amplified with an
AC/DC probe and then acquired with an IDAC-4 interface
board (Syntech, Hilversum NL). A charcoal purified and
humidified airflow was constantly blown over the antennae
(speed 0.5m/s) via a glass tube, placed approximately 1 cm
from the antenna. The tip of a Pasteur pipette containing
an odour-loaded filter paper (5mm × 25mm) was inserted
into a small hole in the glass tube. Odour stimulation
was administered by injecting a puff of purified air (0.5 s
at 10mL/s airflow) through the pipette using the stimulus
delivery controller (Syntech).
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Odour stimuli tested were dissolved in hexane and
presented in series from minor to higher concentration
(resp., 0.01, 0.1, 1, and 10% v/v). 1-Hexanol was chosen for its
well-known stimulant activity in Drosophila [50–52], and 1-
linalool, a terp commonly found in plants, was chosen for
its capability to excite olfactory sensory neurons in different
species of insects [53]. As the standard reference, 1-hexanol
was administered at the 10% v/v dilution at the beginning of
the experiments, to confirm the activity of the antenna. Both
1-hexanol and 1-linalool were purchased from Sigma-Aldrich
(Milan, Italy).
Mean values of EAG amplitude were calculated and then
analysed by comparing the results obtained in LRRKWD40
mutant groups with the age-matched WT control group.
The significance of differences was tested by repeated-
measures ANOVA or one-way ANOVA (followed by HSD
post hoc test) with a threshold level of statistical significance
set at 𝑃 ≤ 0.05 (statistical software package). EAG results
are expressed as average values + SEM and represented by
histograms.
2.3. Olfactory Behaviour. Free-walking bioassays were per-
formed following the experimental procedures used by
Dekker et al. [54]. Briefly, males of WT and LRRKWD40 were
given the opportunity to choose between vials containing
water with or without odour (1-hexanol or 1-linalool). Two
4mL glass vials were placed symmetrically and equally
spaced in a large Petri dish (the arena) and then fitted with
truncated pipette tips. The vials were filled with 300 𝜇L of
water with 0.25% Triton X with or without the odorant. On
the basis of the EAG response, the odour dilution chosen to
trap the flies was 0.1% for both compounds. The dehydration
of flies was prevented by placing a cotton ball with 3mL of
water in the arenas. Flies were starved for 9 hours prior to
starting the experiments. Twelve bioassays were carried out
for each experimental group of flies (15 flies per arena) and for
each odour source and then replicated three times. Bioassays
were performed in controlled environmental conditions and
lasted 18 hours [54] that comprised the most active phase
of olfactory sensitivity [49]. The attraction index (AI) was
calculated as follows: (𝑇 − 𝐶)/(𝑇 + 𝐶 + 𝑁𝑅 − 𝐷), in which
𝑇 is the number of flies in the treatment, 𝐶 is the number in
the control,𝑁𝑅 is the number of living flies remaining in the
arena, and𝐷 is the number of dead flies.
Data obtainedwere expressed as average of percentages of
flies reaching the treatment vial (with 1-hexanol or 1-linalool)
or the control vial (water) and statistically evaluated bymeans
of Student’s 𝑡-test (Statistical software package) with a 95%
confidence level.
2.4. Morphological Observations. For scanning electron
microscopy (SEM), 4–6-day-old flies were anesthetized with
carbon dioxide, immediately immersed in hexane, shaken for
3 minutes to remove the external wax layer, then dehydrated
in a graded ethanol series for ten minutes each concentration
up to absolute ethanol, subsequently air-dried, and finally
glued to stubs and gold coated. At least ten specimens were
prepared and observed using a FEI Quanta 200 high-vacuum
SEM at the Department of Tree Science, Entomology and
Plant Pathology “G. Scaramuzzi,” University of Pisa. The
density of antennal sensilla in both WT and LRRKWD40
mutant males was determined by counting the number of
different types of sensilla present in a sample area enclosed
by an electronic square frame (1,000 𝜇m2) applied to the
SEM screen in the central part of the flagellum. This area
of the flagellum was chosen since it was plain displayed in
all samples and the arrangement of the antennal structures
allowed to count easily the number of each type of sensilla
included by the frame. Moreover, in this area all kinds of
sensilla were present, with the exception of one type (large
basiconic sensilla) located mainly in the basal part of the
flagellum [53]. Sensilla were counted in the flagellar area of
one antenna per specimen; differences in the number of the
three types of sensilla counted in the analysed area of males
of the two strains were evaluated by Student’s t-test with a
95% confidence level (Statistica 6.0, StatSoft, Italy). Higher
magnification was used to study in detail the morphology of
different types of sensilla.
3. Results
3.1. LRRKWD40 Mutants Show Enhancement of the EAG
Response to Both 1-Hexanol and 1-Linalool. As shown in
Figures 1(a) and 2(a), the olfactory stimulations of flies’
antennae with both 1-hexanol and 1-linalool (0.01, 0.1, 1,
and 10% v/v) consistently elicited responses with the typical
EAG waveform, that is, a rapid depolarization followed by a
slower recovery phase, ending with the hyperpolarized wave
before complete reversal to the baseline, in both WT and in
LRRKWD40 mutants, the repolarization phase in LRRKWD40
being slower than WT.
Contrary to expectations, the EAG response values
elicited after stimulation with both 1-hexanol (Figure 1) and
1-linalool (Figure 2) in LRRKWD40 mutants were higher than
those obtained in WT specimens, exhibiting a dose response
for both stimuli administered, although this tendency was
more evident for 1-hexanol. In detail, LRRKWD40 flies showed
a significant increase (𝑃 < 0.05) in the EAG amplitudes with
respect to WT after stimulation with 1-hexanol and 1-linalool
for all concentrations tested, except the lowest (Figures 1 and
2).
3.2. LRRKWD40 Mutants Show Impairment of the Behavioural
Response to Both 1-Hexanol and 1-Linalool. As for the EAG
tests, free-walking bioassays were performed on WT and
LRRKWD40 adult males, by testing the responses to 1-hexanol
or 1-linalool, both at the dilution 0.1% v/v. Contrary to
electrophysiological results, LRRKWD40 males presented a
behavioural impairment, with a significant decrease in the
behavioural scores for both odours with respect to the WT
control groups (Figure 3). In fact, in the trap assays with 1-
hexanol, the percentage of odour-trapped insects was 37 ±
3.7% for LRRKWD40 compared to 71.4 ± 3.7% for WT
control groups; in the case of 1-linalool, only 14.8 ± 3.3% of
LRRKWD40 mutants were attracted in the vial with the odour
as compared to 41.4 ± 3.2% of WT control groups.
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Figure 1: Electroantennogram (EAG) responses to 1-hexanol. Sam-
ple EAG recordings (a) and EAG amplitude values (b) elicited by
stimulation with the different concentrations of 1-hexanol (0.01, 0.1,
1, and 10% v/v) in male antennae of WT and LRRKWD40 mutant
flies. Mean values + SEM from 24–26 antennae for each stimulus
concentration and insect sample. ∗ and ∗∗ indicate significant
differences (𝑃 < 0.05; HSD post hoc test subsequent to one-
way ANOVA or repeated-measures ANOVA) from WT and from
preceding concentration of same stimulus, respectively.
As for the water response, the numbers of trapped flies in
the blank baits were higher for LRRKWD40 compared to WT
(21.3 ± 3 and 11 ± 2.3%, resp., 𝑃 < 0.05) in response to 1-
hexanol, while the number of insects trapped in the blank did
not differ in response to 1-linalool. Moreover, in the latter, no
difference exists betweenmutant insects trapped by the odour
with respect to the blank.
3.3. Morphological Observations. The unexpected increase
in EAG response combined with the impairment of the
behavioural response of mutants with respect to WT led us
to investigate any possible variation in the antennal olfactory
apparatus.
According to our results, no differences are found
between WT and LRRKWD40 flies in the gross structure.
As shown in Figure 4(a), antennae are located between the
compound eyes in two pits separated by a prominent face.The
antennae consist of three segments: scape (basal segment),
pedicel, and flagellum. The pedicel is marked dorsally by a
longitudinal antennal seam. The flagellum, the most relevant
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Figure 2: Electroantennogram (EAG) responses to 1-linalool. Sam-
ple EAG recordings (a) and EAG amplitude values (b) elicited by
stimulation with the different concentrations of 1-linalool (0.01, 0.1,
1, and 10% v/v) in male antennae of WT and LRRKWD40 mutant
flies. Mean values + SEM from 24–26 antennae for each stimulus
concentration and insect sample. ∗ and ∗∗ indicate significant
differences (𝑃 < 0.05; HSD post hoc test subsequent to one-
way ANOVA or repeated-measures ANOVA) from WT and from
preceding concentration of same stimulus, respectively.
sensory area, bears different types of sensilla interspersed
with cuticular setae which are in general markedly curved
and furrowed. There are 4 types of sensilla: trichoid, large
basiconic, small basiconic, and grooved sensilla (Figures
4(b), 4(c), and 4(d)). Trichoid sensilla are the longest, most
predominant sensillawhich are spread in thewhole flagellum;
large basiconic sensilla are present mainly in the basal part of
flagellumand show amultiporous surface (Figure 4(c)), while
small basiconic sensilla are present mainly in the middle and
in the distal part of the flagellum.Grooved sensilla are present
only in the central and in the distal part of the flagellum; they
appear very small and are formed by a series of 6–8 finger-like
projections (Figure 4(d)).
However, as shown in Table 1, significant differences were
found in the mean number of different types of sensilla
counted in the selected area of flagellum between WT and
LRRKWD40 mutants.
In detail, as a general pattern, mutants show a higher
number of all sensilla in the considered area than WT
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Figure 3: Behavioural olfactory response to 0.1% v/v 1-hexanol (a) and 0.1% v/v 1-linalool (b) inWT and LRRKWD40mutant flies. Mean values
of trapped males + SEM; experiments in triplicate; 𝑛 = 12 bioassays for each experimental group of flies, 𝑛 = 15 flies per arena. ∗ indicates
significant differences (𝑃 < 0.05; Student’s t-test) with respect to WT.
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Figure 4: Scanning electronmicrographs ofD.melanogasterWTmale. (a) Head showing the antennal pattern: scape (s), pedicel (p), antennal
seam (as), flagellum (f), and face (fa). (b) Magnification of the central part of flagellum with sensilla: trichoid sensillum (ts), small basiconic
sensillum (sbs), and setae (s). (c) High magnification of the basal part of the flagellum showing some large basiconic sensilla with porous wall
(lbs). (d) High magnification of different types of sensilla in the central part of flagellum with a grooved sensillum (gs).
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Table 1: Average number (±SD) of the three types of sensilla present
in a sample area (1,000𝜇m2) in the central part of the flagellum of
D. melanogaster WT and LRRKWD40 mutants (Student’s 𝑡-test, 95%
confidence level).
Type of sensilla Wild type (𝑛 = 7) LRRKWD40 (𝑛 = 8) 𝑃
Trichoid
sensilla 8.86 ± 1.06 11.50 ± 1.07 0.00036
Small
basiconic
sensilla
2.00 ± 0 2.63 ± 0.74 0.04549
Grooved
sensilla 0.86 ± 0.38 1.50 ± 0.53 0.02003
flies, although these differences are evident only at high
magnification (Figure 5). As a matter of fact, the number of
trichoid sensilla in LRRKWD40 mutants males exceeded the
WT number with highly significant difference (𝑃 ≤ 0.001).
Similarly, also small basiconic and grooved sensilla were
present in LRRKWD40 mutants males with a slightly higher
density than in the WT males (𝑃 ≤ 0.05).
4. Discussion
The aim of this study was to estimate in the PD trans-
lational model Drosophila melanogaster any possible olfac-
tory dysfunction correlated to a specific LRRK2 mutation
(LRRKWD40) [43], by analogy with a previous study in a
PINK1 Drosophilamodel [9, 46].
The used LRRK2 translational model most closely
approximates human LRRK2 G2385R mutation, which
occurs in the human WD40 domain and is a risk factor for
PD, mainly in Asian populations [21].
Contrary to PINK1B9 [9, 46], where the EAG response
was lower with respect to the WT, our results showed that
the LRRKWD40 mutant, compared to the WT, presents an
unexpected dramatic increase in the amplitude of the EAG
responses and this is coupled with a higher number of
olfactory sensilla.
Nevertheless, similarly to what was observed for PINK1B9
[46] also the LRRKWD40 mutants present an impairment in
the behavioural response to odours.
4.1. LRRKWD40 Mutants Show Enhancement of the EAG
Response to Both 1-Hexanol and 1-Linalool. In detail, even if
LRRKWD40 shows an increase in EAG response at any con-
centration to both tested stimuli (1-hexanol and 1-linalool),
at the lowest one, no differences in threshold were found
between mutants andWT. Despite the great variability in the
sensilla number in different strains [55], we cannot exclude
the notion that the electrophysiological response is due to the
higher sensillar density found in the flagellum of LRRKWD40
compared to WT, mostly in consideration of the relevant
number of trichoid sensilla which can cause an increased
summed antennal sensitivity. Further, we cannot exclude a
role of the perireceptor environment in the chemoreceptor
response. In this respect, it is possible that in mutants more
odorant binding proteins could be present and/or interact
with the odorants more tightly, but the presence of a dimin-
ished concentration of the odour degrading enzymes is also
possible [56–58]. Accordingly, Corvol et al. [59] found in PD
patients a persistent increase in an olfactory type G-protein
(Golf ) that was first identified in the olfactory epithelium
[60, 61] homologous to the olfactory sensilla in Drosophila
antennae.
More recently, Yun and Park [62], analysing shape and
amplitude of the EAG curve, indicated some parameters for
the analysis of the EAG curve, with the peak amplitude
being the most important one and therefore it is widely
used for studying the odour detection. According to these
authors, other parameters like the shape cannot be used for
odorant concentration measurements but they can help in
discriminating between different odorants. In this respect,
our results show that EAGs evoked by 1-linalool are longer
than those evoked by 1-hexanol. The overall lower amplitude
of the EAG in response to 1-linalool with respect to 1-hexanol
is also in accordance with the data in literature, according to
which the former interacts with a reduced number of ORs
with respect to the latter [50].
4.2. LRRKWD40 Mutants Show Impairment of the Behavioural
Response to Both 1-Hexanol and 1-Linalool. Looking at the
behavioural response to the odours, 1-hexanol attracts a
number of insects statistically higher than 1-linalool, in both
WT and mutant flies, but the number of LRRKWD40 mutants
trapped is lower than WT regardless of the stimulus tested.
As for the functional significance of the two stimulants, 1-
hexanol was reported to involve both the appetitive and the
aversive response in flies, even if with great variability in its
effects [51, 63], and it interacts with a number of olfactory
receptor neurons (ORNs) distributed on the small and the
large basiconic and on the trichoid sensilla [50, 53, 64]. In this
respect, our behavioural data point to a prevailing appetitive
response to 1-hexanol, thus making the differences with the
above reported data in literature. 1-Hexanol is reported to also
interact with a number of olfactory receptors (ORs) located in
the trichoid ones responding to pheromones [64] that could
give reason for the attractive effects we observed. In other
words, we suggest possible sex-related differences, that is,
male used in the present study versus male and female in a
1 : 1 ratio in the study by Knaden et al. [51].We cannot exclude
other possible methodological differences among different
studies. Analogous considerations can be made for 1-linalool
that was previously reported to be an aversive stimulus [51]
but that may also interact with the pheromone-sensitive
OR19a in the trichoid sensilla [64].
As for the response to water, in our opinion, results
showing that LRRK2 mutants are trapped by water in the 1-
hexanol experiments and especially the absence of difference
between water and the odour in the case of 1-linalool
point to an impairment in the discrimination capability of
LRRK2 mutants. In fact, even if mutants present a higher
electrophysiological response to both stimuli with respect to
WT, the percentage of mutants which goes to the odours
under a double-choice situation is about half that ofWT flies.
These results can be attributable to an impairment we found
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Figure 5: Scanning electron micrographs of flagellum of D. melanogaster WT (a) and LRRKWD40 mutant (b); (ai and bi) the respective
magnifications of the central area with the frame used to count the density of sensilla.
in the mitochondrial morphology in the antennal lobes [43],
where olfactory neurons project.
4.3.Morphological Observations. Our observations on anten-
nal flagellum ofDrosophilaWTmales showed the presence of
four types of sensilla as previously reported [65] and mapped
for this species [53]; further, the LRRKWD40 mutant did
not display noticeable gross morphological differences with
respect to the WT, but a general increase in the number of
sensilla in the central part of the flagellumwas highlighted. As
far as we know, no data are available to correlate the number
of sensilla with LRRK function; we recall that LRRK2 is
known to be involved in cytoskeleton assembly [22], but how
a deletion of WD40 domain can be correlated to an increase
of sensilla number is hard to hypothesize. In this respect,
we recall that researches on lozenge Drosophila mutants
showed changes at different extent in morphological features
of antennal sensilla, including a reduction or an increase in
the number and/or lack of some sensilla [66].
4.4. Concluding Remarks. Our functional approach to merg-
ing olfactory sensory electrophysiology with behavioural
response was used to go in depth in the analysis of odour
detectionwith the aimof considering olfaction as a diagnostic
marker for PD in the LRRKWD40.
Our results show that, despite the dose-response relation-
ship and the unexpected high EAG amplitude which point
to a “normal” olfactory function, the LRRKWD40 mutants
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present an impairment in the behavioural response to odours.
In this respect in a pioneeristic work on human odour
stimuli detection in correlating electrophysiological activity
from human olfactory bulb and the subjective response to
stimuli, Hughes et al. [67] stated “the significance of this type
of correlation remains questionable as long as there is no
indication of the total response of the organism.”
In conclusion, our results suggest that olfactory behav-
ioural impairment is a common feature for two Drosophila
PDmodels such as LRRKWD40 and PINK1B9 [46] despite the
two opposite electrophysiological peripheral responses and
highlight the fact thatDrosophila is a powerful model also for
the LRRK2 loss-of-function variant.
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